老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioLine Rx

3.25
-0.1900-5.52%
盤後：3.24-0.0100-0.31%16:05 EDT
成交量：1.84萬
成交額：6.10萬
市值：1,209.33萬
市盈率：-0.70
高：3.43
開：3.43
低：3.24
收：3.44
資料載入中...
總覽公司新聞公告
2021/01/11

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/23

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/11/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/01

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/26

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/06/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/20

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多